Glaxosmithkline Share News (GSK)

MARKET COMMENT: UK Shares Close Lower As EU Agrees Sanctions

Britain's FTSE dips on Ukraine nerves; RBS outperforms

* FTSE 100 closes down 0.4 pct after late selloff * Traders run for exit as Russia accuses Ukraine of selling * RBS jumps 11 pct as UK upturn boosts results * BSkyB falls 5.5 pct on news of 4.9 bln pound acquisition By Francesco Canepa LONDON, July 25 (Reuters) - Bri

FTSE 100 movers: RBS tops the leaders after surprise H1 profit

RBS delivered a better-than-expected first half operating performance, but said no one at the 80% taxpayer-owned bank was "complacent about the challenges ahead". The results, which came a week earlier than scheduled, showed operating profit totalled £2.6bn, or £3.3bn excluding restructuring and l

Banks outperform Britain's FTSE after RBS's bumper results

* FTSE 100 down 0.2 pct on the day, up for the week * RBS jumps 11 pct as UK upturn boosts results * BSkyB falls 5 pct on news of 4.9 bln pound acquisition * GSK pegs back FTSE on corruption allegations By Francesco Canepa LONDON, July 25 (Reuters) - British lenders

Edelman subsidiary questioned in China TV anchor investigation

BEIJING, July 25 (Reuters) - An investigation into a celebrity anchorman at state broadcaster China Central Television (CCTV) has widened to a subsidiary of U.S. public relations company Edelman, the subsidiary said on Friday. Chinese authorities visited the Beijing office of Pegasus Public

Glaxo To "Thoroughly Investigate" Syria Misconduct Claims

Europe backs new leukaemia drugs from J&J and Gilead

LONDON, July 25 (Reuters) - Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said on Friday its experts had issued positive op

UK WINNERS & LOSERS: Carillion, Balfour Up As Merger Talks Confirmed

TOP NEWS: RBS Surprises With Strong Profits; BSkyB Buys Fox Stakes

Banks outpace flat UK FTSE after RBS's bumper results

* FTSE 100 flat * RBS jumps 14 pct as UK upturn boosts results * GSK pegs back FTSE on corruption allegations By Francesco Canepa LONDON, July 25 (Reuters) - British lenders who focus on the domestic market outpaced a flat FTSE 100 index on Friday after strong results from

Friday broker round-up UPDATE

African Barrick Gold: Investec places both its target price (prev.: 212p) and its sell recommendation under review. Westhouse Securities ups target price from 250p to 285p upgrading from neutral to add. Barclays: Deutsche Bank cuts target price from 300p to 275p staying with its buy recommendation.

UK BROKER RATINGS: UBS Cuts GlaxoSmithKline To Sell From Neutral

Britain's FTSE edges down ahead of growth data, RBS soars

* FTSE 100 down 0.1 pct, investor sentiment muted on earnings * Q2 GDP data in focus after IMF upgrades * RBS jumps 14 pct, biggest one-day gain in four years * BSkyB deal hits shares, Burberry weaker on LVMH LONDON, July 25 (Reuters) - UK shares edged lower in early tradi

UK MORNING BRIEFING: BSkyB And Balfour-Carillion Put M&A In Focus

PRESS: GlaxoSmithKline Facing Bribery Allegations In Syria - Reuters